Integrative analysis with expanded DNA methylation data reveals common key regulators and pathways in cancers
Preprint
Abstract
The integration of genomic and DNA methylation data has been demonstrated as a powerful strategy in understanding cancer mechanisms and identifying therapeutic targets. The TCGA consortium has mapped DNA methylation in thousands of cancer samples using Illumina Infinium Human Methylation 450K BeadChip (Illumina 450K array) that only covers about 1.5% of CpGs in the human genome. Therefore, increasing the coverage of the DNA methylome would significantly leverage the usage of the TCGA data. Here, we present a new model called EAGLING that can expand the Illumina 450K array data 18 times to cover about 30% of the CpGs in the human genome. We applied it to analyze 13 cancers in TCGA. By integrating the expanded methylation, gene expression and somatic mutation data, we identified the genes showing differential patterns in each of the 13 cancers. Many of the triple-evidenced genes identified in the majority of the cancers are biomarkers or potential biomarkers. Pan-cancer analysis also revealed the pathways in which the triple-evidenced genes are enriched, which include well known ones as well as new ones such as axonal guidance signaling pathway and pathways related to inflammatory processing or inflammation response. Triple-evidenced genes, particularly TNXB, RRM2, CELSR3, SLC16A3, FANCI, MMP9, MMP11, SIK1, TRIM59, showed superior predictive power in both tumor diagnosis and prognosis. These results have demonstrated that the integrative analysis using the expanded methylation data is powerful in identifying critical genes/pathways that may serve as new therapeutic targets.Keywords
All Related Versions
- Published version: npj Genomic Medicine, 4 (1), 1.
This publication has 59 references indexed in Scilit:
- Regions of common inter-individual DNA methylation differences in human monocytes: genetic basis and potential functionEpigenetics & Chromatin, 2017
- Evaluation of MiR-34 Family and DNA Methyltransferases 1, 3A, 3B Gene Expression Levels in Hepatocellular Carcinoma Following Treatment with Dendrosomal NanocurcuminAsian Pacific Journal of Cancer Prevention, 2016
- Predicting CpG methylation levels by integrating Infinium HumanMethylation450 BeadChip array dataGenomics, 2016
- Computationally expanding infinium HumanMethylation450 BeadChip array data to reveal distinct DNA methylation patterns of rheumatoid arthritisBioinformatics, 2016
- Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine TumorClinical Cancer Research, 2016
- Triple-layer dissection of the lung adenocarcinoma transcriptome - regulation at the gene, transcript, and exon levelsOncotarget, 2015
- FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathwayCell Death & Disease, 2014
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- DNA Methylation Data Analysis and its Application to Cancer ResearchEpigenomics, 2013
- Comparative Serum Proteome Analysis of Human Lymph Node Negative/Positive Invasive Ductal Carcinoma of the Breast and Benign Breast Disease Controls via Label-Free Semiquantitative Shotgun TechnologyOMICS: A Journal of Integrative Biology, 2009